Arturo Jose Borzutzky Schachter, MD | |
300 Longwood Ave, Fegan 6, Boston, MA 02115-5724 | |
(617) 355-5727 | |
(317) 730-0249 |
Full Name | Arturo Jose Borzutzky Schachter |
---|---|
Gender | Male |
Speciality | Pediatrics - Pediatric Rheumatology |
Location | 300 Longwood Ave, Boston, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730349903 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 233340 (Massachusetts) | Secondary |
2080P0216X | Pediatrics - Pediatric Rheumatology | 233340 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Arturo Jose Borzutzky Schachter, MD 300 Longwood Ave, Fegan 6, Boston, MA 02115-5724 Ph: (617) 355-5727 | Arturo Jose Borzutzky Schachter, MD 300 Longwood Ave, Fegan 6, Boston, MA 02115-5724 Ph: (617) 355-5727 |
News Archive
The primary focus of many patients attending a psychiatric consultation for mood instability is to obtain an explanation for their symptoms, report researchers.
Advocates and experts examine progress made since the Institute of Medicine released its landmark report that called for the elimination of medical errors, or "never events," ten years ago. Modern HealthCare interviews Helen Haskell, who founded the advocacy organization Mothers Against Medical Error, and examines progress and shortcomings: "Families are still losing loved ones to errors, Haskell explained during a recent conference hosted by Consumers Union. But the biggest difference in the past 10 years is, 'where once there was denial, we now have tireless leaders.'"
"[F]inally, we're getting some reliable data suggesting how to" help people in developing countries because of economists, who "provide answers that are rigorously field-tested, akin to the way drugs are tested in randomized controlled trials, yielding results that are particularly credible and persuasive," Nicholas Kristof writes in his New York Times column.
Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration has approved Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.
PrimeraDx, a molecular diagnostics company, announced today that the ICEPlex C. difficile Assay Kit and the ICEPlex System have received 510(k) clearance from the United States Food and Drug Administration.
› Verified 6 days ago
Puja Banka, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Bader 203, Boston, MA 02115 Phone: 617-355-6363 | |
Angela M. Jacques, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 Phone: 617-726-2066 | |
Dr. Elizabeth Susan Taglauer, M.D., PH.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Cailyn Hereen Rood, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Dr. Alon Peltz, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Miki Nishitani, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 | |
Vickren Pillay, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 |